Effects of rituximab and dexamethasone on regulatory and pro ‐inflammatory B‐cell subsets in patients with primary immune thrombocytopenia

ConclusionBoth treatment regimens normalized the frequencies of cytokine‐producing B cells. The additional increase in CD5+ B cells after RTX+DXM is compatible with induction of Bregs.This article is protected by copyright. All rights reserved.

Source: European Journal of Haematology - September 27, 2017 Category: Hematology Authors: Sif Gudbrandsdottir, Marie Brimnes, Tania K øllgaard, Hans C Hasselbalch, Claus H Nielsen Tags: Original Article Source Type: research